Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eprosartan versus eprosartan mesylate in essential hypertension
2010-019155-22Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of eprosartan in essential hypertension (2 arms), sponsored by Abbott Laboratories. Primary endpoint: Change in trough sitting diastolic blood pressure. Started Mar 2012; status: completed.
02
Drugs
eprosartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2010-019155-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019155-22.